This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Eight-one percent of subjects reported “at least moderate improvement in their condition … without experiencing serious adverse events.”
179 : The VA Medicinal Cannabis Research Act of 2019 to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans. Furthermore, twenty-two percent of respondents said they themselves “use cannabis to treat a mental or physical condition.”
The conditions of the relevant licenses and permits. Comply with relevant workplace health and safety legislation. Yesespecially in safety-sensitive industries (mining, transport, healthcare). Employers must balance workplace safety with disability discrimination laws. Data Privacy 29.
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.
According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. Public health and safety programs. General funds.
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.
The 2017 expansion of Virginia’s medical marijuana law got rid of qualifying conditions. How did getting rid of qualifying conditions make things easier for Virginia’s patients and the legislature? So, we set about these two objectives, one being to add additional conditions.
Quest Diagnostics started analyzing yearly workplace drug testing data 25 years ago in 1988, and the result of their recent study was published on May 18. However, it is important to note that Quest Diagnostics amphetamines data does not separate prescribed medications like Adderall from illicit drug use.
Marijuana may be a lucrative opportunity on the surface, but there are several conditions that could put the industry out of reach for some time. South America needs safe, reliable growing materials, cannot use certain pesticides, needs to meet cleanliness and safety standards, etc. Strict Regulations. .
Christopher Simpson, a deputy director at the Pacific Northwest Agricultural Safety and Health Center, believes that overall, the risk of DDE in cannabis is likely low. “To There just isn’t experimental data available,” Simpson said. There just isn’t experimental data available,” Simpson said.
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc.
Of these consumers, over half said the drug had a beneficial clinical effect on their condition. As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Parkinson’s disease and cannabis.
Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.
terpenes ) may help treat a number of different skin conditions. Some of these have been identified as possible targets for the treatment of inflammatory skin conditions. Can cannabis make inflammatory skin conditions worse? The results were very positive and showed the safety and effectiveness of the topical CBD.
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
The warning letters were released just a few days following Gottlieb’s testimony to a Senate subcommittee, in which he announced that his agency would use enforcement discretion against CBD product manufacturers who are making “over-the-line claims.”.
There is also an association with an increase in phlegm production, and a potential increase in certain respiratory conditions. Vaping may reduce tar exposure compared to smoke , but there are still concerns around the safety of oil vaporizers, especially after the EVALI crisis, which took dozens of American lives.
million adults are now using “street cannabis ” to treat the symptoms of chronic conditions , according to the largest poll of its kind. More than half (56 per cent) of those using cannabis for their conditions did so on a daily basis, with a further 23 per cent on a weekly basis. They write.
The review period will give employers a chance to identify safety-sensitive positions for which the new drug test ban is not appropriate. SB 5132 already has a number of exceptions built-in for safety-sensitive jobs like law enforcement, firefighting, and first responders. So, how exactly is ketamine able to do this?
The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future.
The approval, made through the European Commission Decision Reliance Procedure (ECDRP), is based on data from a positive Phase 3 safety and efficacy study evaluating 25 mg/kg/day of GW’s cannabidiol. The safety profile observed was consistent with findings from previous studies, with no new safety risks identified.
By focusing on this specific demographic, the team aimed to not only collect raw data but also gain insights into the motivations and experiences that led these caregivers to explore CBD as a therapeutic option for their children. Always consult a physician before making any decision on the treatment of a medical condition.
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.
The buddie can be paired with a mobile app that tracks consumption, correlating it with health data from devices like WHOOP, Apple Watch, or Fitbit. Emphasizing data privacy, Maya’s innovation includes options to keep records on the user’s phone and easily delete data.
However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5. Easy access. What’s in your CBD?
This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. Training will be provided within the research program for licensed practitioners to assess the safety of psychedelic medicines and to classify and report positive and adverse events.
The Rules aim to promote social equity, safety and easy access to the cannabis marketplace while keeping local municipalities in control of how they want cannabis businesses to operate in their jurisdiction. New applicants may apply for either a conditional license or an annual license.
Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.
The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety.
Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients. A 2022 meta-analysis of 23 studies published in Clinical Pharmacology & Therapeutics found that therapeutic effects plateau at relatively low doses for most conditions.
Cancer Pain Relief With Cannabis: What the New Study Shows Utilizing data from the Quebec Cannabis Registry in Canada, researchers sought to examine the safety and effectiveness of cannabis in addressing cancer pain. Always consult a physician before making any decision on the treatment of a medical condition.
It is also a tool used to “determine the nature and scope of child abuse and neglect” and compare Arizona data to national trends, regardless of whether that neglect or abuse arose from the lawful or unlawful use of substances, a mental illness or incapacity, or simply an inability to properly care for a child. 600 USD raised of $400 goal.
In other words, BCP may aid in treating or preventing a multitude of conditions like infections, spasms, pain, and other neurologic conditions. It is generally regarded as safe (GRAS) according to the FDA, meaning companies may include it in products with relative confidence of its safety. Shutterstock). Andriy Popov/123rf).
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.
We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We
Applied topically, cannabis can bring relief to a host of issues including aches and pains, inflammation, itching, rashes, skin conditions like acne, eczema, and psoriasis, skin cancers, and much more. We currently have little data and science to go on as to optimal topical dosages. Find small plastic bottles here.
According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. In September, the state expanded its list of qualifying conditions , allowing veterans with PTSD and cancer patients to join the program.
Whereas some might believe steps taken by governments and organizations to screen and/or prevent cannabis use are supported by empirical evidence, such commentary is often based on speculation, vested interests, and pseudo-science rather than on objective interpretation of all available scientific data.
The hearing was intended to listen, question, and ultimately understand the scientific data, general information, and immediate issues surrounding CBD products that will need to be addressed as FDA considers legal pathways for CBD. Several speakers expressed a deep concern for consumers that use and depend on CBD to treat certain conditions.
Tetragram users log their sessions by data points like strain , product, intake method, how it helped their symptoms, how it looked and tasted, and where they bought it. As co-founder Otha Smith said, “through data, we aim to empower not only cannabis consumers, but the entire industry.”. Oh, and users can always upload photos as well.
FDA has not reviewed the manufacturing process of these unapproved CBD-containing drug products, so the manufacturing conditions of, or contaminant levels in, these products is unknown. He added that significant data is still needed to inform policy regarding use of consumer cannabis products.
According to MS Society of Canada , 1 in every 385 Canadians lives with this condition. As it’s one of the most debilitating conditions, living with multiple sclerosis is a real battle. Since so little is known about the exact cause of this condition, and a cure hasn’t been found yet, treatment options are limited but they do exist.
Dr. Maxwell’s team also collected data contained in samples sourced from California. After a close analysis of the data, the team determined that an absence of consistent federal guidelines regarding marijuana contaminants ultimately increases the risk of consumers developing health issues.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content